{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:08:46Z","timestamp":1784920126273,"version":"3.55.0"},"reference-count":54,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["Finance Code 001."],"award-info":[{"award-number":["Finance Code 001."]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Evidence Based Medicine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1111\/jebm.12414","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T13:53:05Z","timestamp":1602683585000},"page":"255-260","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["SARS\u2010CoV\u20102 virus infection: Targets and antiviral pharmacological strategies"],"prefix":"10.1111","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4016-3018","authenticated-orcid":false,"given":"Daniel Melo de Oliveira","family":"Campos","sequence":"first","affiliation":[{"name":"Department of Biophysics and Pharmacology Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-9878","authenticated-orcid":false,"given":"Umberto Laino","family":"Fulco","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Pharmacology Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Bruno Silva","family":"de Oliveira","sequence":"additional","affiliation":[{"name":"Maria Alice Fernandez Pediatric Hospital, Natal, Rio Grande do Norte  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1646-921X","authenticated-orcid":false,"given":"Jonas Ivan Nobre","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Department of Biophysics and Pharmacology Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.2020.01012"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30374-3"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01533-w"},{"key":"e_1_2_12_5_1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/09546634.2020.1742438","article-title":"Should patients stop their biologic treatment during the COVID\u201019 pandemic","volume":"31","author":"Basgyam AM","year":"2020","journal-title":"J Dermatolog Treat"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017"},{"key":"e_1_2_12_7_1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1590\/1519-6984.238155","article-title":"Fighting COVID\u201019","volume":"80","author":"Campos DMO","year":"2020","journal-title":"Braz J Biol"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25681"},{"key":"e_1_2_12_9_1","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.3346\/jkms.2020.35.e176","article-title":"Perspectives of immune therapy in coronavirus disease 2019","volume":"35","author":"Gasparyan AY","year":"2020","journal-title":"J Korean Med Sci"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.058"},{"key":"e_1_2_12_11_1","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.3389\/fimmu.2020.01664","article-title":"Identification of SARS\u2010CoV\u20102 cell entry inhibitors by drug repurposing using in silico structure\u2010based virtual screening approach","volume":"11","author":"Choudhary S","year":"2020","journal-title":"Front Immunol"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/v8100296"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-020-00016-0"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"e_1_2_12_15_1","article-title":"Homology modeling of TMPRSS2 yields candidate drugs that may inhibit entry of SARS\u2010CoV\u20102 into human cells","author":"Rensi S","year":"2020","journal-title":"ChemRxiv"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104792"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01043-16"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30076-X"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2020.02.001"},{"key":"e_1_2_12_21_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS\u2010CoV\u20102 3CLpro and anti\u2010COVID\u201019 drug discovery from medicinal plants","volume":"10","author":"Ul Tahir","year":"2020","journal-title":"J Pharm Anal"},{"key":"e_1_2_12_22_1","unstructured":"2020 Z Xu C Peng Y Shi Nelfinavir was predicted to be a potential inhibitor of 2019\u2010nCov main protease by an integrative approach combining homology modelling molecular docking and binding free energy calculation"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2008.07.030"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2020.01030"},{"key":"e_1_2_12_25_1","first-page":"E008","article-title":"Efficacies of lopinavir\/ritonavir and abidol in the treatment of novel coronavirus pneumonia","volume":"12","author":"Chen J","year":"2020","journal-title":"Chin J Infect Dis"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101647"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"e_1_2_12_29_1","first-page":"170","article-title":"Potential antiviral therapeutics for 2019 Novel Coronavirus","volume":"43","author":"Li H","year":"2020","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101615"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.03.007"},{"key":"e_1_2_12_32_1","article-title":"COVID\u201019: attacks the 1\u2010beta chain of hemoglobin and captures the porphyrin to inhibit human heme metabolism","author":"Liu W","year":"2020","journal-title":"ChemRxiv"},{"key":"e_1_2_12_33_1","unstructured":"FDA.Coronavirus (COVID\u201019) Update: Daily Roundup March 30 2020. Available at:https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-daily-roundup-march-30-2020. Accessed on 12nd September 2020."},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa114"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.40"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2020.03.006"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-0156-0"},{"issue":"2","key":"e_1_2_12_39_1","first-page":"215","article-title":"A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease\u201019 (COVID\u201019)","volume":"49","author":"Chen J","year":"2020","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"e_1_2_12_40_1","article-title":"Chloroquine, but not hydroxychlorquine, prolongs the QT interval in a primary care population","author":"Isaksen JL","year":"2020","journal-title":"MedRxiv"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012410"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05073-9"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.3906\/sag-2004-145"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2016.04.001"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104787"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105944"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30132-8"},{"key":"e_1_2_12_48_1","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S1473-3099(20)30262-0","article-title":"Baricitinib for COVID\u201019: a suitable treatment","volume":"20","author":"Favalli EG","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"e_1_2_12_49_1","first-page":"1","article-title":"Network\u2010based drug repurposing for novel coronavirus 2019\u2010nCoV\/SARS\u2010CoV\u20102","volume":"6","author":"Zhou Y","year":"2020","journal-title":"Cell Discov"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114184"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-020-01049-6"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30317-2"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3379"},{"issue":"1","key":"e_1_2_12_54_1","first-page":"147","article-title":"Management of corona virus disease\u201019 (COVID\u201019): the Zhejiang experience","volume":"49","author":"Xu K","year":"2020","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2020.06.017"}],"container-title":["Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jebm.12414","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jebm.12414","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jebm.12414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T10:15:07Z","timestamp":1693822507000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jebm.12414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1111\/jebm.12414"],"URL":"https:\/\/doi.org\/10.1111\/jebm.12414","archive":["Portico"],"relation":{},"ISSN":["1756-5383","1756-5391"],"issn-type":[{"value":"1756-5383","type":"print"},{"value":"1756-5391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"2020-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}